CDSCO bans 35 unapproved Fixed Dose Combinations (FDCs) due to health risks. Immediate halt to production and sale ordered. Check the full list.

A 12mg dose led to six per cent weight loss over the 10 months, and a 3mg dose five per cent. People taking a fake pill lost 1.6 per cent. The popularity of GLP-1 slimming injections has rocketed ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1 ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in 2026.

In a 40-week study, more than 500 people with type 2 diabetes were given either a placebo or one of three possible doses (3mg, 12mg and 36mg) of the drug, orforglipron. Those taking the highest ...

The trial randomized 559 participants to receive either 3 mg, 12 mg, or 36 mg orforglipron or placebo. Also Read: Eli Lilly’s Mounjaro Launch Triggers Weight-Loss Drug Craze In India ...

GlobalData is the parent company of Clinical Trials Arena. In the randomised, placebo-controlled, double-blind ACHIEVE-1 trial (NCT05971940), the efficacy and safety of three doses – 3mg, 12mg and ...

Glimepiride IP 3mg + Dapagliflozin Propanediol Monohydrate IP eq. to Dapagliflozin 10mg film coated bilayered tablets FDC of: (i) Dextromethorphan Hydrobromide IP 10mg + Phenylephrine Hydrochloride IP ...